September 4, 2020 Acad, Gov/Utilities Liq. Handling & Robotics Microscopy PR/Corporate

Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems

First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample As COVID-19 and influenza infections can hardly be differentiated based on symptoms, healthcare professionals can confidently provide the right diagnosis and best course of treatment for patients Test for use... Read more

September 1, 2020 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Danaher Appoints Rainer M. Blair As President And CEO

Danaher Appoints Rainer M. Blair As President And CEO WASHINGTON, Sept. 1, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has implemented its previously disclosed succession plan and appointed Rainer M. Blair as President and Chief Executive Officer and a member of the Board of... Read more

September 1, 2020 Acad, Gov/Utilities Bio/Pharma/CRO Microscopy PR/Corporate

Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDS

Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management of patients with HIV – from appropriate counseling on disease differences to targeted therapy Supports rapid molecular detection of acute HIV infection, which is critical in curbing further disease transmission Combines confirmatory HIV testing and HIV-1/HIV-2 differentiation into... Read more

August 6, 2020 PR/Corporate

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020

SAN DIEGO–(BUSINESS WIRE)—- $ILMN #ILMN–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020. Second quarter 2020 results reflect the impact of the global COVID-19 pandemic: Revenue of $633 million, a 25% decrease compared to $838 million in the second quarter of 2019 GAAP net income attributable to... Read more

August 5, 2020 Microscopy PR/Corporate

【Delayed】Consolidated Financial Statements for the First Quarter Ended June 30, 2020 FY2021 (April 1, 2020 – June 30, 2020)

Home Corporate Guide Message from the president Corporate Data Corporate History Corporate Executives Directions to Takara Bio Sustainability Initiatives Business Outline News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese... Read more

August 4, 2020 PAI Top-10 PR/Corporate

Luminex Corporation Reports Second Quarter 2020 Results

Delivers Accelerated Organic Growth and Profitability AUSTIN, Texas, Aug. 4, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its second quarter ended June 30, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT FINANCIAL HIGHLIGHTS Total revenue for the second quarter of $109.5M, a 32%... Read more

August 3, 2020 PR/Corporate

Bio-Techne Announces Appointment of Julie L. Bushman to Its Board of Directors

MINNEAPOLIS, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company’s board of directors, effective as of July 31, 2020.  Following the appointment, the board of Bio-Techne will be comprised of ten directors, nine of whom are independent.  Bushman, 59, is the former... Read more